Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians.

Yokoyama, Hitoshi; Okuyama, Hiroshi; Yamaya, Hideki

Lupus nephritis comprises a spectrum of glomerular, vascular, and tubulointerstitial lesions, which has significant racial variation in severity and manifestations. The current classification (ISN/RPS 2003) has been improved successfully for the categorization of lupus glomerulonephritis (LGN). On the basis of this classification, 480 Japanese cases revealed the following distribution: class I 3%, class II 16%, class III 13%, class IV-S 11%, class IV-G 41%, class V 16%, and class VI 1%. Class IV-G with chronicity tended to have the worst renal outcome. Nephrotic syndrome was a more frequent complication in class IV-S (50%), class IV-G (72%), and class V (56%), with poor renal and actuarial outcomes. With regard to therapy, treatment options including glucocorticoids alone or combined with antimetabolites (azathioprine, mizoribine, mycophenolate mofetil), calcineurin inhibitors (cyclosporine A, tacrolimus), or alkylating agents (intravenous cyclophosphamide injection) improved the outcome of LGN; however, there is no high-grade clinical evidence from Japan. Further studies are needed to resolve the clinicopathological problems of LGN, especially IV-S, IV-G, and pure membranous lupus nephritis in Japanese patients.

LUPUS nephritis; CLINICAL pathology; NEPHROTIC syndrome; ALKYLATING agents; GLUCOCORTICOIDS; JAPANESE people; ASIANS; HEALTH & race; DIAGNOSIS; DISEASES

Clinical & Experimental Nephrology, 2011, Vol 15, Issue 3, p321

1342-1751

Academic Journal

10.1007/s10157-011-0434-0